Diversified Healthcare Trust Common Shares of Beneficial Interest (DHC) is a publicly traded Real Estate sector company. As of May 20, 2026, DHC trades at $9.15 with a market cap of $2.08B and a P/E ratio of -5.76. DHC moved +6.29% today. Year to date, DHC is +76.25%; over the trailing twelve months it is +179.21%. Its 52-week range spans $2.00 to $9.14. Analyst consensus is buy with an average price target of $8.17. Rallies surfaces DHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Diversified Healthcare Q4 FFO Misses by 25%, Revenue Slides 4.5%: Diversified Healthcare reported Q4 FFO of $0.09 per share, missing the $0.12 consensus and compared with $0.02 a year earlier. Q4 revenue stood at $379.57 million, 4.5% below estimates and flat year-on-year, while shares have climbed 28.7% year-to-date.
| Metric | Value |
|---|---|
| Price | $9.15 |
| Market Cap | $2.08B |
| P/E Ratio | -5.76 |
| EPS | $-1.55 |
| Dividend Yield | 0.01% |
| 52-Week High | $9.14 |
| 52-Week Low | $2.00 |
| Volume | 2.56M |
| Avg Volume | 0 |
| Revenue (TTM) | $1.50B |
| Net Income | $-370.25M |
| Gross Margin | 0.00% |
3 analysts cover DHC: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.17.